Our collaboration with Intel Corporation continues as Intel’s Head of Lab and Life Sciences, Sandra Colner, interviews two of ValitaCell’s senior management team.
Building the Future of Labs: Adopting New Technologies to Navigate Change
In the first of our podcast series, ValitaCell’s Head of Data, Dr. Paul Dobson, joins Sandra Colner to provide an overview of the CELLIMAGE project and mission and talks about the role of the project in improving cell therapy manufacturing.
AI and Cell Therapy Intersect to Revolutionize the Biopharma Industry
Our second podcast in the series with Intel features ValitaCell’s Head of Cell Therapy, Stephanie Davies, who discuss how the AI-driven transformation being experienced by the biopharmaceutical industry has the potential to solve cell therapy’s manufacturing challenges and offer solutions to previously untreatable diseases. Listen back to Intel’s “Health and Life Sciences at the Edge” podcast here.